Okihara Koji, Yorozu Atsunori, Saito Shiro, Tanaka Nobumichi, Koga Hirofumi, Higashide Satoshi, Kikuchi Takashi, Nakano Masahiro
Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Department of Radiation Oncology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
Int J Urol. 2017 Jul;24(7):518-524. doi: 10.1111/iju.13358. Epub 2017 Apr 28.
To evaluate male sexual function in Japanese prostate cancer patients undergoing permanent brachytherapy without endocrine treatment, using quality of life measures of the Expanded Prostate Cancer Index Composite.
A total of 482 patients were selected as analysis subjects from the nationwide database for the Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation. The patients were asked to complete the Expanded Prostate Cancer Index Composite questionnaires before and at 3, 12, 24, and 36 months after the permanent brachytherapy. Changes in their responses were analyzed, and any association of the outcomes was investigated. Furthermore, changes over time in their answers to Q18 (usual quality of your erections) were analyzed.
A total of 72 patients (14.9%) had received external beam radiation. A total of 68 patients (14.1%) had taken any 5-phosphodiesterase inhibitor medications. Regarding Q18, 232 patients (48.2%) selected either "There was no sexual activity" or "There was no desire for erection" before receiving permanent brachytherapy. Of all the 482 patients, sexual function was preserved in 138 patients (28.7%) 3 years after permanent brachytherapy. Overall satisfaction has significantly improved without regard for the deterioration of sexual function. Significant factors for maintaining sexual activity were patient age and sexual activity before permanent brachytherapy.
In Japanese patients undergoing permanent brachytherapy alone for prostate cancer, the sexual function is not well preserved. However, decreased sexual function does not seem to represent a major factor determining patients' overall satisfaction. These findings might be peculiar to Japanese patients, in whom elderly subjects account for the majority.
使用扩展前列腺癌指数综合生活质量指标,评估未接受内分泌治疗的日本前列腺癌患者在接受永久性近距离放射治疗后的男性性功能。
从日本永久性碘-125粒子植入前列腺癌结局研究的全国数据库中选取482例患者作为分析对象。要求患者在永久性近距离放射治疗前以及治疗后3、12、24和36个月完成扩展前列腺癌指数综合问卷。分析他们的回答变化,并调查结果的任何相关性。此外,分析他们对问题18(你勃起的通常质量)的回答随时间的变化。
共有72例患者(14.9%)接受了外照射放疗。共有68例患者(14.1%)服用过任何5-磷酸二酯酶抑制剂药物。关于问题18,232例患者(48.2%)在接受永久性近距离放射治疗前选择了“没有性活动”或“没有勃起欲望”。在所有482例患者中,永久性近距离放射治疗3年后,138例患者(28.7%)的性功能得以保留。总体满意度显著提高,而不考虑性功能的恶化。维持性活动的重要因素是患者年龄和永久性近距离放射治疗前的性活动。
在仅接受永久性近距离放射治疗的日本前列腺癌患者中,性功能保留不佳。然而,性功能下降似乎并不是决定患者总体满意度的主要因素。这些发现可能是日本患者所特有的,因为日本老年患者占大多数。